Pages that link to "Q37681343"

The following pages link to Genetics of osteoporosis: accelerating pace in gene identification and validation (Q37681343):

Displaying 45 items.

• Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function (Q24299076) (← links)
• Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation (Q28236701) (← links)
• WNT signaling in bone homeostasis and disease: from human mutations to treatments (Q28285090) (← links)
• Gene expression profiling suggests a pathological role of human bone marrow-derived mesenchymal stem cells in aging-related skeletal diseases (Q28567479) (← links)
• Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium (Q30579240) (← links)
• Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (Q31082788) (← links)
• Gender-specific DNA methylome analysis of a Han Chinese longevity population (Q33562413) (← links)
• Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women (Q33574081) (← links)
• Synopsis and meta-analysis of genetic association studies in osteoporosis for the focal adhesion family genes: the CUMAGAS-OSTEOporosis information system (Q33804359) (← links)
• The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors (Q34428195) (← links)
• The genetics of bone loss: challenges and prospects (Q34894261) (← links)
• Relationship between CATSPERB, NR5A2 gene polymorphisms and Peak Bone Mineral Density in College Students in China (Q35545100) (← links)
• Gene expression changes in human mesenchymal stem cells from patients with osteoporosis (Q35628505) (← links)
• Association of the I264T variant in the sulfide quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women. (Q35741489) (← links)
• Value of rare low bone mass diseases for osteoporosis genetics (Q36440123) (← links)
• Genome-wide approaches for identifying genetic risk factors for osteoporosis (Q36998445) (← links)
• OPG rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration (Q37107900) (← links)
• Clinical impact of recent genetic discoveries in osteoporosis (Q37230278) (← links)
• Genetic factors influencing bone mineral content in a black South African population (Q37302449) (← links)
• A Candidate Gene Association Study of Bone Mineral Density in an Iranian Population (Q37368927) (← links)
• The role of midkine in skeletal remodelling (Q37585395) (← links)
• Pharmacogenetics of Osteoporosis-Related Bone Fractures: Moving Towards the Harmonization and Validation of Polymorphism Diagnostic Tools (Q37791155) (← links)
• A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution (Q37912798) (← links)
• The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans (Q38687054) (← links)
• Connecting Bone and Fat: The Potential Role for Sclerostin (Q39350147) (← links)
• Polymorphisms in VDR gene in Tunisian postmenopausal women are associated with osteopenia phenotype (Q39432542) (← links)
• Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women (Q39672688) (← links)
• The genetic profile of bone repair (Q42252513) (← links)
• Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men. (Q44243690) (← links)
• Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer (Q44680094) (← links)
• Replication study of three functional polymorphisms associated with bone mineral density in a cohort of Spanish women. (Q46946218) (← links)
• Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. (Q51373847) (← links)
• Genetic predisposition to non-union: evidence today. (Q52841943) (← links)
• MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity. (Q53090118) (← links)
• An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes. (Q55019978) (← links)
• Effects of Type 2 Diabetic Serum on Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells. (Q55386970) (← links)
• Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis (Q57487017) (← links)
• Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study (Q57558980) (← links)
• Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts (Q57848796) (← links)
• The Relationship between Polymorphisms in the Vitamin D Receptor Gene and Bone Mineral Density in Postmenopausal Women (Q59047874) (← links)
• Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women (Q87619623) (← links)
• Postmenopausal Osteoporosis reference genes for qPCR expression assays (Q91235007) (← links)
• The association of genetic variants in FGFR2 with osteoporosis susceptibility in Chinese Han population (Q92198232) (← links)
• An insight into the paradigms of osteoporosis: From genetics to biomechanics (Q92356884) (← links)
• Vitamin D-conjugated gold nanoparticles as functional carriers to enhancing osteogenic differentiation (Q93135147) (← links)